Novo CEO pressed by Senate to cut selling prices of obesity, diabetes medicines CEO Lars Fruergaard Jørgensen instructed lawmakers the business would take into account new talks with insurers with regard to the listing charges of Wegovy and copyright whenever they pledge to maintain the medicines on their formularies. Investment https://dave-s-hot-chicken-nutrit83726.tblogz.com/a-simple-key-for-healthcare-news-unveiled-44672697